ULSAN, South Korea, Feb. 14 (Korea Bizwire) — A team of South Korean researchers has developed a groundbreaking diagnostic technique that can detect lung cancer using only a few drops of blood. Scientists at the Ulsan National Institute of Science and Technology (UNIST) announced on February 13 that they have created EV-CLIP, a technology capable of [...]
SEOUL, March 15 (Korea Bizwire) — Workers at school cafeterias are being exposed to the risk of lung cancer due to the carcinogens emitted during cooking. 14 local education offices conducted health examinations on 24,065 cafeteria workers with more than 10 years of experience, among whom 139 people were suspected of having lung cancer. Among [...]
SHANGHAI, China and REDWOOD CITY, Calif., Sept. 14 (Korea Bizwire) — Shanghai Junshi Biosciences Co., Ltd. (“Junshi Biosciences”, HKEX: 1877; SSE: 688180) and Coherus Biosciences, Inc. (Nasdaq: CHRS) announced the presentation today of positive interim results from the pivotal study “CHOICE-01” (NCT03856411), a randomized, double-blind, placebo-controlled Phase 3 clinical trial evaluating toripalimab plus chemotherapy as [...]
SHANGHAI, China, and REDWOOD CITY, Calif., Aug. 18 (Korea Bizwire) — Shanghai Junshi Biosciences Co., Ltd. (“Junshi Biosciences”, HKEX: 1877; SSE: 688180) and Coherus BioSciences, Inc. (“Coherus”, Nasdaq: CHRS), today announced positive interim results from the pivotal study “CHOICE-01” (NCT03856411), a randomized, double-blind, placebo-controlled Phase 3 clinical trial evaluating toripalimab plus chemotherapy as first-line treatment of advanced squamous or [...]
Press Briefing with International Researchers Explores this Question at IASLC 2020 World Conference on Lung Cancer Singapore To view a recording of the press briefing, visit: https://vimeo.com/506248459/caa7346336 SINGAPORE, Jan. 29 (Korea Bizwire) — On February 27, 2020, the flagship journal of the International Association for the Study of Lung Cancer, the Journal of Thoracic Oncology, published a [...]
SINGAPORE, Jan. 28 (Korea Bizwire) — Several leading international lung cancer researchers at a press today presented compelling new data revealing that factors of race, gender, sexual orientation and income continue to be significant barriers to those living with lung cancer. The press briefing is part of the IASLC’s World Conference on Lung Cancer 2020 Singapore. [...]
SINGAPORE, Jan. 28 (Korea Bizwire) — In the phase II CodeBreak 100 trial, sotorasib provided durable clinical benefit with a favorable safety profile in patients with pretreated non-small cell lung cancer (NSCLC) and who harbor KRAS p.G12C mutations, validating CodeBreak 100’s phase I results, according to research presented today at the International Association for the Study of [...]
LONDON, Nov. 27 (Korea Bizwire) — Only one in five people (22%) disagree with the statement “generally, patients with lung cancer have caused their illness through their lifestyle choices and behaviors,” according to a global, omnibus survey conducted by Ipsos MORI and sponsored by the Lung Ambition Alliance. The results were released to coincide with the [...]
BARCELONA, Spain, Sept. 7 (Korea Bizwire) — Today, at the IASLC World Conference on Lung Cancer, the four founding partners of the Lung Ambition Alliance – the International Association for the Study of Lung Cancer (IASLC), Guardant Health, the Global Lung Cancer Coalition (GLCC) and AstraZeneca – announced the launch of several new initiatives to [...]
LONDON, Jul. 8 (Korea Bizwire) — Today, the International Association for the Study of Lung Cancer (IASLC), Guardant Health, the Global Lung Cancer Coalition (GLCC) and AstraZeneca announced the Lung Ambition Alliance, a new partnership with a bold ambition to eliminate lung cancer as a cause of death. The first goal of the Alliance will [...]